G01N2800/168 - CPC Classification Index

#1

20260009804

2026-01-08

ANTIBODIES THAT BIND TO NATIVELY FOLDED MYOCILIN

#2

20230314435

2023-10-05

MARKER OF CALCIUM-OVERLOAD-MEDIATED NEURONAL DEATH AND APPLICATION THEREOF

#3

20230260126

2023-08-17

PROCESSING FUNDUS IMAGES USING MACHINE LEARNING MODELS

#4

20230227910

2023-07-20

COMPOSITIONS AND METHODS OF USING RNA FRAGMENTS

#5

20220026445

2022-01-27

ANTIBODIES THAT BIND TO NATIVELY FOLDED MYOCILIN

#6

20210389332

2021-12-16

GDF15 in glaucoma and methods of use thereof

#7

20210209762

2021-07-08

Processing fundus images using machine learning models

#8

20210059524

2021-03-04

Method for detecting glaucoma

#9

20200341010

2020-10-29

PREDICTIVE BIOMARKERS FOR TREATMENT OF EYE DISEASES

#10

20200325537

2020-10-15

Compositions and methods of using RNA fragments

#11

20200157499

2020-05-21

Method for differentiation into retinal ganglion cells from stem cells

#12

20190180441

2019-06-13

Processing fundus images using machine learning models

#13

20190011458

2019-01-10

GDF15 in glaucoma and methods of use thereof

#14

20180162871

2018-06-14

Fluorescent probe for detecting calpain activity

#15

20180092531

2018-04-05

Method for detecting glaucoma

#16

20180045738

2018-02-15

Methods of use for intermediate filament protein probes

#17

20180020908

2018-01-25

SYSTEMS AND METHODS FOR DETERMINING RETINAL GANGLION CELL POPULATIONS AND ASSOCIATED TREATMENTS

#18

20170080060

2017-03-23

Methods of delivering a polypeptide molecule to Otx2 target cells using an Otx2 targeting peptide

#19

20130172204

2013-07-04

Diagnostic methods for glaucoma

#20

20120064532

2012-03-15

Use of Serum Amyloid A Gene in Diagnosis and Treatment of Glaucoma and Identification of Anti-Glaucoma Agents

#21

20120015884

2012-01-19

Polypeptides for Specific Targeting to Otx2 Target Cells

#22

20110124009

2011-05-26

COMPOSITION, KIT AND METHOD FOR ASSAYING NEUROPATHY

#23

20110065646

2011-03-17

Methods of reducing excitotoxicity-induced retinal ganglionic neuron degeneration by an orthodenticle HOMOLOG2 (OTX2) homeoprotein

#24

20100204311

2010-08-12

Normal-tension glaucoma model and method for evaluation of test substances by using same

#25

20100003707

2010-01-07

GLAUCOMA BIOMARKER

#26

20090226425

2009-09-10

Diagnostics and Therapeutics For Glaucoma

#27

20090220469

2009-09-03

PEPTIDES AGAINST AUTOANTIBODIES ASSOCIATED WITH GLAUCOMA AND USE OF THESE PEPTIDES

#28

20090036371

2009-02-05

Use of Serum Amyloid A Gene in Diagnosis and Treatment of Glaucoma and Identification of Anti-Glaucoma Agents

#29

20080305103

2008-12-11

Treatment of ocular disease with inhibitors of alpha2 macroglobulin protein

#30

20080085878

2008-04-10

Superoxide dismutase-2 expression for glaucoma diagnosis

#31

20080058429

2008-03-06

Diagnosis Of Primary Open Angle Glaucoma

#32

20070249010

2007-10-25

Methods for treating glaucoma and macular degeneration

#33

20060286636

2006-12-21

VEGF variants

#34

20060216732

2006-09-28

Diagnostics and therapeutics for glaucoma

#35

20050170430

2005-08-04

Diagnosis and treatment of glaucoma and methods for discovering new glaucoma therapeutic agents based on the wnt/ca2+ signaling pathway

#36

20050170353

2005-08-04

Gene examination method for judging the onset risk of glaucoma

#37

20050164907

2005-07-28

Diagnosis and treatment of glaucoma and methods for discovering new glaucoma therapeutic agents based on the wnt/planar cell polarity (pcp) signaling pathway

#38

20050153927

2005-07-14

Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents